Prof. Dr. Yvan Arsenijevic is the Head of the Retinal Degeneration Mechanisms Pole at the University of Lausanne. He graduated as a biologist in the Department of Pediatric and Genetics at Geneva University, Switzerland, in 1990. He pursued his training in neurosciences at the University of Geneva. From 1995 to 1997, he joined the team of Professor Sam Weiss at the University of Calgary, Canada, who isolated and identified neural stem cells during development and in the adult brain. Back in Switzerland from 1997 to 2000, Y. Arsenijevic worked at the University of Lausanne in the team of Patrick Aebischer and demonstrated that the adult human brain contains multipotent progenitors in different brain areas. Since 2011, Yvan Arsenijevic has been an Associate Professor at the University of Lausanne at the Jules-Gonin Eye Hospital, where he developed a research laboratory center at the Department of Ophthalmology and focused on retinal degeneration mechanisms and regenerative medicine using gene therapy strategies and pluripotent cells to validate therapeutic approaches. To facilitate preclinical studies, he generated, with Bruce Whitelaw at the University of Edinburgh, transgenic pigs developing retinal dystrophies. He received the 2013 Alfred Vogt Encouraging Award and the Global Ophthalmology Awards Program from Bayer, the 2017 Alfred Vogt Prize, and the Prix Claire et Selma Kattenburg in 2018 (Arsenijevic & Mbefo).